Co-op, LNP Discovery
Strand Therapeutics
Summary
Strand is looking for a highly motivated and innovative candidate for the role of Co-op, LNP Discovery. This is a fantastic opportunity to make a significant impact as a scientifically motivated self-starter capable of independently conceiving, conducting, and critically analyzing his/her own work with minimal supervision.
Job description
Job Summary
Strand is looking for a highly motivated and innovative candidate for the role of Co-op, LNP Discovery. This is a fantastic opportunity to make a significant impact as a scientifically motivated self-starter capable of independently conceiving, conducting, and critically analyzing his/her own work with minimal supervision.
Primary Responsibilities
- Executing formulation related experiments including preparing, optimizing, and characterizing the LNP formulations.
- Carrying out some bioassays for evaluating the LNP formulations.
- Facilitating general lab techniques such as sample preparation, cell culture, and nucleic acid work.
- Working across diverse areas to support the group's research activities in a fast-paced and collaborative environment.
Qualifications
- On track to graduate with a B.S. or M.S. in Biology, Biochemistry, Bioengineering, or a related discipline.
- Coursework related to dosage forms, drug/gene delivery system, and nanotechnology are desirable.
- Experience with production and analytical characterization of LNP formulation is a big plus.
- Ability to write, edit, and follow standard operating procedures, make careful observations, maintain clear and complete records of lab work.
Requirements
- On track to graduate with a B.S. or M.S. in Biology, Biochemistry, Bioengineering, or a related discipline
- Coursework related to dosage forms, drug/gene delivery system, and nanotechnology are desirable
- Experience with production and analytical characterization of LNP formulation is a big plus
- Ability to write, edit, and follow standard operating procedures
- Ability to make careful observations and maintain clear and complete records of lab work
Company overview
Strand Therapeutics is a pioneering biotechnology company founded in 2017 by researchers from MIT's Synthetic Biology Center. The company is developing the world's first platform for creating programmable, long-acting mRNA therapeutics capable of delivering precise, multi-functional, and potentially curative treatments. Strand's innovative approach involves embedding mRNA therapeutics with sophisticated genetic logic circuits that enable them to identify specific cell types and activate only in diseased cells, while remaining inactive in healthy tissues. This technology dramatically increases the therapeutic window and safety profile of mRNA medicines. The company's proprietary mRNA programming language allows for precise control over the location, timing, intensity, and duration of protein expression, representing a significant advancement in synthetic biology applications for medicine. Strand is currently advancing a pipeline of programmable mRNA therapeutics focused on cancer and other life-threatening diseases, with their lead candidate STX-001 already in Phase 1 clinical trials for solid tumors. The company has raised over $256 million in funding from prominent investors including Kinnevik, Regeneron, Eli Lilly, and Amgen.